Renaissance Technologies.
The book · Q2 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | NVDA | NVIDIA CORPORATION | 7.09M | $1.4B | 2.0% | +181% |
| 2 | META | META PLATFORMS INC | 2.02M | $1.1B | 1.6% | +698% |
| 3 | INTC | INTEL CORP | 7.32M | $1.0B | 1.4% | −1% |
| 4 | UTHR | UNITED THERAPEUTICS CORP DEL | 1.71M | $926M | 1.3% | −4% |
| 5 | PLTR | PALANTIR TECHNOLOGIES INC | 7.57M | $883M | 1.2% | +8% |
| 6 | GOOGL | ALPHABET INC | 2.32M | $828M | 1.1% | +327% |
| 7 | EXEL | EXELIXIS INC | 13.43M | $731M | 1.0% | −2% |
| 8 | VRSN | VERISIGN INC | 2.45M | $616M | 0.8% | −13% |
| 9 | KGC | KINROSS GOLD CORP | 24.75M | $585M | 0.8% | −3% |
| 10 | CRWD | CROWDSTRIKE HLDGS INC | 749K | $572M | 0.8% | NEW |
Where the money is
AC read
Renaissance Technologies' 13F for Q2 2026, covering the period ending June 30, 2026 and filed with the SEC with the standard 45 to 90 day lag, shows a $72.6 billion book spread across 3,140 positions, with a Herfindahl index of 0.003 that confirms the portfolio carries no concentrated bets. The top ten holdings account for just 12.0% of assets, led by Nvidia at $1.4 billion (2.0%), Meta at $1.1 billion (1.6%), and Intel at $1.0 billion (1.4%), followed by smaller stakes in Unitedhealth... correction, United Therapeutics (UTHR) at $926 million, Palantir at $883 million, and Alphabet at $828 million. Sector exposure is similarly spread out, with technology at 11.3%, semiconductors at 8.5%, media at 7.6%, biotechnology at 6.9%, and retail at 6.2%, none of which comes close to dominating the book.
Read the full dossier →